From:  Investigation of peripheral rat blood immune phenotype to evaluate the biocompatibility of graphene nanoparticles and xenografted mesenchymal stem cells

 Panel of fluorescent-tagged monoclonal antibodies and their immune-cell subtype targets.

GroupAntibodiesCell types
ICD3 (FITC) + CD45RA (RPE)B Lymphocytes, T Lymphocytes
IICD11b (A488) + CD161 (RPE)Natural Killer Cells, Macrophages + Monocytes + Dendritic Cells + Granulocytes
IIICD4 (A488) + CD8a (RPE)Cytotoxic T-Cells + Natural Killer Cells, Helper T-Cells + Monocytes
IVRT1B (RPE) + IgM (FITC)B Lymphocytes
VCD11b (Pacific Blue) + RT1B (FITC) + CD86 (RPE)Macrophages + Monocytes + Dendritic Cells + Granulocytes, Dendritic Cells + Macrophages + B Lymphocytes
VICD68 (A488) + CD11b (Pacific Blue) + CD163 (RPE) Macrophages, Macrophages + Monocytes + Dendritic Cells + Granulocytes
VIICD43 (FITC)Leukocytes
VIIIUnstained controlN/A
IXCD45 (A488)Leukocytes + B Lymphocytes

Samples of rat peripheral blood were divided and stained with fluorescent-tagged monoclonal antibodies. Each antibody targeted a specific protein associated with an immune-cell subtype. The mean fluorescence was quantified as a percentage of the total of 40,000 cells per sample.